1112 related articles for article (PubMed ID: 23775566)
1. The paracrine effect of cancer-associated fibroblast-induced interleukin-33 regulates the invasiveness of head and neck squamous cell carcinoma.
Chen SF; Nieh S; Jao SW; Wu MZ; Liu CL; Chang YC; Lin YS
J Pathol; 2013 Oct; 231(2):180-9. PubMed ID: 23775566
[TBL] [Abstract][Full Text] [Related]
2. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition.
Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC
Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049
[TBL] [Abstract][Full Text] [Related]
3. A novel stromal lncRNA signature reprograms fibroblasts to promote the growth of oral squamous cell carcinoma via LncRNA-CAF/interleukin-33.
Ding L; Ren J; Zhang D; Li Y; Huang X; Hu Q; Wang H; Song Y; Ni Y; Hou Y
Carcinogenesis; 2018 Mar; 39(3):397-406. PubMed ID: 29346528
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages.
Takahashi H; Sakakura K; Kudo T; Toyoda M; Kaira K; Oyama T; Chikamatsu K
Oncotarget; 2017 Jan; 8(5):8633-8647. PubMed ID: 28052009
[TBL] [Abstract][Full Text] [Related]
5. Autocrine and paracrine loops between cancer cells and macrophages promote lymph node metastasis via CCR4/CCL22 in head and neck squamous cell carcinoma.
Tsujikawa T; Yaguchi T; Ohmura G; Ohta S; Kobayashi A; Kawamura N; Fujita T; Nakano H; Shimada T; Takahashi T; Nakao R; Yanagisawa A; Hisa Y; Kawakami Y
Int J Cancer; 2013 Jun; 132(12):2755-66. PubMed ID: 23180648
[TBL] [Abstract][Full Text] [Related]
6. Reciprocal activation of cancer-associated fibroblasts and oral squamous carcinoma cells through CXCL1.
Wei LY; Lee JJ; Yeh CY; Yang CJ; Kok SH; Ko JY; Tsai FC; Chia JS
Oral Oncol; 2019 Jan; 88():115-123. PubMed ID: 30616781
[TBL] [Abstract][Full Text] [Related]
7. PDGF-AA mediates mesenchymal stromal cell chemotaxis to the head and neck squamous cell carcinoma tumor microenvironment.
Watts TL; Cui R; Szaniszlo P; Resto VA; Powell DW; Pinchuk IV
J Transl Med; 2016 Dec; 14(1):337. PubMed ID: 27931212
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of head and neck squamous cell carcinoma proliferation, invasion, and metastasis by tumor-associated fibroblasts in preclinical models.
Wheeler SE; Shi H; Lin F; Dasari S; Bednash J; Thorne S; Watkins S; Joshi R; Thomas SM
Head Neck; 2014 Mar; 36(3):385-92. PubMed ID: 23728942
[TBL] [Abstract][Full Text] [Related]
9. Driving role of head and neck cancer cell secretome on the invasion of stromal fibroblasts: Mechanistic insights by phosphoproteomics.
Prieto-Fernandez L; Villaronga MLA; Hermida-Prado F; Hijazi M; Montoro-Jimenez I; Pevida M; Llames S; Rodrigo JP; Cutillas P; Calvo F; Garcia-Pedrero JM; Alvarez-Teijeiro S
Biomed Pharmacother; 2023 Feb; 158():114176. PubMed ID: 36916400
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal interaction between carcinoma-associated fibroblasts and squamous carcinoma cells through interleukin-1α induces cancer progression.
Bae JY; Kim EK; Yang DH; Zhang X; Park YJ; Lee DY; Che CM; Kim J
Neoplasia; 2014 Nov; 16(11):928-38. PubMed ID: 25425967
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway.
Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W
Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283
[TBL] [Abstract][Full Text] [Related]
12. Separation of cell survival, growth, migration, and mesenchymal transdifferentiation effects of fibroblast secretome on tumor cells of head and neck squamous cell carcinoma.
Metzler VM; Pritz C; Riml A; Romani A; Tuertscher R; Steinbichler T; Dejaco D; Riechelmann H; Dudás J
Tumour Biol; 2017 Nov; 39(11):1010428317705507. PubMed ID: 29157176
[TBL] [Abstract][Full Text] [Related]
13. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients.
Pavón MA; Arroyo-Solera I; Téllez-Gabriel M; León X; Virós D; López M; Gallardo A; Céspedes MV; Casanova I; López-Pousa A; Mangues MA; Quer M; Barnadas A; Mangues R
Oncotarget; 2015 Oct; 6(30):29016-33. PubMed ID: 26359694
[TBL] [Abstract][Full Text] [Related]
14. Melanoma differentiation-associated gene-7/interleukin-24 as a potential prognostic biomarker and second primary malignancy indicator in head and neck squamous cell carcinoma patients.
Wang L; Feng Z; Wu H; Zhang S; Pu Y; Bian H; Wang Y; Guo C
Tumour Biol; 2014 Nov; 35(11):10977-85. PubMed ID: 25091574
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity to Cisplatin in Head and Neck Cancer Cells Is Significantly Affected by Patient-Derived Cancer-Associated Fibroblasts.
Peltanova B; Liskova M; Gumulec J; Raudenska M; Polanska HH; Vaculovic T; Kalfert D; Grega M; Plzak J; Betka J; Masarik M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671869
[TBL] [Abstract][Full Text] [Related]
16. Cancer-associated fibroblasts in the invasive tumour front promote the metastasis of oral squamous cell carcinoma through MFAP5 upregulation.
Wang Y; Wang R; Li B; Huang Z; Zhao S; Chen S; Lan T; Ren S; Wu F; Tan J; Li J
Gene; 2023 Aug; 876():147504. PubMed ID: 37217152
[TBL] [Abstract][Full Text] [Related]
17. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
[TBL] [Abstract][Full Text] [Related]
18. Loss of RUNX3 expression inhibits bone invasion of oral squamous cell carcinoma.
Park J; Kim HJ; Kim KR; Lee SK; Kim H; Park KK; Chung WY
Oncotarget; 2017 Feb; 8(6):9079-9092. PubMed ID: 28030842
[TBL] [Abstract][Full Text] [Related]
19. Tumor microenvironment in head and neck squamous cell carcinoma.
Curry JM; Sprandio J; Cognetti D; Luginbuhl A; Bar-ad V; Pribitkin E; Tuluc M
Semin Oncol; 2014 Apr; 41(2):217-34. PubMed ID: 24787294
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive activity of cancer-associated fibroblasts in head and neck squamous cell carcinoma.
Takahashi H; Sakakura K; Kawabata-Iwakawa R; Rokudai S; Toyoda M; Nishiyama M; Chikamatsu K
Cancer Immunol Immunother; 2015 Nov; 64(11):1407-17. PubMed ID: 26201938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
